Skip to main content
BMC Nephrology logoLink to BMC Nephrology
. 2018 Feb 28;19:49. doi: 10.1186/s12882-018-0849-x

Quality of life in hemodialysis diabetic patients: a multicenter cross-sectional study from Palestine

Sohaib T Khatib 1, Mohammad K Hemadneh 1, Samer A Hasan 1, Emad Khazneh 2, Sa’ed H Zyoud 3,4,
PMCID: PMC5831192  PMID: 29490623

Abstract

Background

Both diabetes and hemodialysis can seriously impair patients’ health related quality of life (HRQOL). This study seeks to obtain data which will help to address the factors associated with impaired HRQOL in hemodialysis patients with diabetes in Palestine.

Methods

A cross-sectional study was performed in multiple centers in the period from November 2016 to June 2017. We utilized the Arabic version of EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) scale and EuroQol-visual analogue scale (EQ-VAS) to measure patients’ HRQOL. The study was conducted in six dialysis centers in the North of West Bank, Palestine. Descriptive and comparative statistics were used to describe clinical and socio-demographic features of patients. Multiple linear regression analysis was used to determine the association between clinical and socio-demographic factors and HRQOL score.

Results

One hundred and forty one diabetic patients undergoing hemodialysis were enrolled in our study. Overall, 52.5% of them (74 patients) were males; the patients had a mean age of 60.32 with 52.5% of them aged below 60. The mean ± standard deviation of EQ-5D-5L index and EQ-VAS score was 0.314 ± 0.4 and 50.85±22.43, respectively. The findings of this study suggest that female patients, uneducated patients, unemployed patients, unmarried patients, and patients with more chronic diseases and comorbidities had a significant poor HRQOL scores (p values <0.05). Variables such as marital status and occupational status were significantly (p < 0.05) associated with the QOL score. More specifically, married status and employed patients positively associated with QOL score (β = 0.22; p = 0.016 and β = 0.27; p = 0.013, respectively).

Conclusions

Among diabetic patients undergoing hemodialysis, married status and being employed were associated with modestly higher scores of QOL. We recommend that healthcare providers give more attention to diabetic dialysis patients who are unemployed and unmarried, as they are at a higher risk of having impaired HRQOL.

Electronic supplementary material

The online version of this article (10.1186/s12882-018-0849-x) contains supplementary material, which is available to authorized users.

Keywords: Diabetes mellitus, Hemodialysis, Health-related quality of life, Palestine, HRQOL

Background

Type II diabetes mellitus (DM) is a major long-standing metabolic disorder causing a remarkable load on patients and their community in terms of mortality and morbidity [1]. It causes serious short-term and long-term complications; in the long term, it can lead to microvascular complications (e.g. nephropathy) and macrovascular complications (e.g. myocardial infarction) [2]. Diabetic nephropathy, which occurs in about one third of type 2 diabetic patients, is the most common factor leading to end-stage renal disease (ESRD). Despite recent therapeutic advances [3], its yearly incidence has more than doubled in the last decade to reach 44% of all ESRD [4]. The substantial increase in hemodialysis patients with DM is prone to rise even more as the population is getting older, the incidence of obesity is rising, and more people are surviving their cardiovascular incidents [5].

Health-related quality of life (HRQOL) is the individual’s beliefs, experiences, perceptions and expectations standing for enjoyment in those aspects of life probably influenced by health condition[6]. HRQOL is identified as a vital health outcome for studies evaluating the quality of healthcare, assessing the influence of illness and analyses of cost-effectiveness [7, 8]. Lower HRQOL scores lead to significant risk of hospitalization and mortality. HRQOL is a significant matter for dialysis patients and also for DM patients [9, 10]. The degree of HRQOL is considerably lower for those patients than for the public in spite of breakthroughs in the treatment of end-stage renal disease and DM [11]. Furthermore, HRQOL has been discovered to be a forecaster of mortality in both diabetic patients [12] and patients on hemodialysis [13, 14].

In reviewing the literature, there were several studies directed towards hemodialysis patients with DM. For example, Martínez-Castelao et al. [15] found that diabetic patients starting dialysis in Spain have lower HRQOL in contrast to non-diabetics. Another study showed that DM was one of the major determinants of mortality in patients on hemodialysis [5]. In Denmark, one study found that diabetic dialysis patients are characterized by reduced self-rated physical health, a high prevalence of diabetic complications, but relatively good mental health. Despite these studies, no one has specifically targeted the factors associated with impaired HRQOL among diabetic patients undergoing hemodialysis.

According to the 2016 annual health record of the Palestinian Ministry of Health, 5,761 new case of DM had been reported this year in West Bank [16]. Moreover, the total number of diabetic patients with nephropathy complications was 5,176. The overall number of dialysis patients in the West Bank has jumped from 687 patients in 2014 to 1,004 patients in 2015 which showed substantial increase in patients requiring hemodialysis [16].

Although HRQOL is a new research field in Palestine, multiple studies have recently examined HRQOL in Palestine among hypertensive [17], cancer [18], diabetic [6] and dialysis patients [19]. Despite these valuable studies, no one has specifically studied HRQOL among diabetic patients undergoing hemodialysis. Therefore, we carried out the study reported here to determine the patterns of HRQOL and to describe the significant factors associated with low HRQOL scores among Palestinian diabetic patients whose declining kidney function mandated initiation of renal replacement therapy using hemodialysis.

Methods

Study design

We performed this multicenter cross-sectional study in the period between November 2016 and August 2017.

Study setting

The study was conducted in six dialysis centers in the North of West Bank, Palestine. These included the dialysis centers in Nablus, Tulkarem, Jenin, Qalqelia, Tubas and Salfeet. Five of them are centers at the government hospital in each city; only the center at Nablus is at a teaching hospital. We used annual health records of the Palestinian Ministry of Health to gather information regarding the numbers and distribution of diabetic and dialysis patients [16].

Study population

At the time of our study, the total number of dialysis patients in these six cities was 507 patients; furthermore, the total number of hemodialysis machines was 92 machines. The distribution of patients and hemodialysis machines for each city was as follows: Nablus 210 patients (33 machines), Tulkarem 78 patients (13 machines), Jenin 113 patients (16 machines), Qalqelia 47 patients (10 machines), Tubas 27 patients (12 machines), Salfeet 32 patients (8 machines). Zyoud et al [19] found that 45% of hemodialysis patients in Palestine are diabetic, so the population of our study was estimated to be 230 patients.

Sample size

We used a web-based calculator (Raosoft sample size calculator) to calculate our sample size, which was 141 patients. We increased our sample size by 7% to cover patients not responding to our study.

Participants and sampling technique

One hundred and forty one patients were recruited by a reliable quota sampling method proportional to the number of patients in each dialysis center. We set five inclusion criteria for patients participating in our study, which were: (1) patients who have confirmed diagnosis of end-stage renal disease according to their medical files; (2) Patients who reported having type 2 DM; (3) Patients aged 18 years or more; (4) Patients who have been on regular hemodialysis for more than six months; (5) Patients with a history of DM for more than one year. We excluded patients with cognitive restrictions that made independent responses to the questionnaire impossible.

Data sources and variables

The questionnaire we used to gather data from patients contained two sections, one for clinical history and socio-demographic information and the other for the validated Arabic version of HRQOL [20]. In the first section, we included the following socio-demographic characteristics: patient’s gender, age, weight and height (for calculating body mass index (BMI)), residency (village, city or Palestinian refugee camp) [6], educational level, living arrangements (living alone or with family), marital status, occupation, monthly household income, and whether the patient was a smoker or not. The clinical factors included in our study were: total number of chronic medications, total number of chronic diseases, time since DM was diagnosis, average duration of dialysis session, months on dialysis, history of kidney transplantation, and glycated haemoglobin (HbA1c) level. We categorized monthly household income as low (less than 400 Jordanian dinner (JD)), moderate (400–1000 JD) or high (more than 1000 JD) [17]. We also categorized HbA1c level as controlled (HbA1c ≤ 7%) or uncontrolled (HbA1c more than 7%) [21, 22]. We used the 5-level EuroQoL Group’s 5-dimension (EQ-5D-5L) questionnaire to estimate the health status and quality of life (QOL) for diabetic dialysis patients. EQ-5D is a standardized instrument for use as a measure of health outcome [23]. This questionnaire is a five-item scale assessing five separate dimensions of health: (MOBILITY, SELF-CARE, USUAL ACTIVITIES, PAIN/DISCOMFORT and ANXIETY/DEPRESSION). Each dimension has to be answered on a five–level scale (no problems, slight problems, moderate problems, severe problems and extreme problems). We also used the EQ visual analogue scale (EQ-VAS), which measures the subjects' perspectives on their QOL using a 100-point scale [23]. We used the Arabic version of EQ-5D [17, 19, 24] according to Euro QOL guidelines. We also registered our study with Euro quality of life and obtained permission for its use (ID: 20964). An additional file was supplied to illustrate detailed description of the study both in English and Arabic (Additional file 1). Cronbachs’ alpha for our study indicated acceptable internal consistency for EQ-5D-5L scale (α= 0.79). EQ-5D was scored using United Kingdom general population scoring algorithm (i.e. EQ-5D-5L Crosswalk Index Value Calculator) to calculate the index value using the value sets (weights) [25].

Data collection procedure

After obtaining permission from the education department at Ministry of Health (MOH), we got access to patients’ medical records at each dialysis center to determine diabetic patients among those on hemodialysis. We also identified patients who met our inclusion criteria and invited them to participate in the study. We interviewed one hundred and forty one patients, we chose to meet them face-to-face to make the interview very comfortable for both patients and interviewers, and also to allow patients who aren’t able to read to have the chance to participate in our study. Interviews were carried out by qualified medical students from An Najah National University. After interviewing each patient, a blood sample was withdrawn from each patient by a qualified registered nurse at each dialysis center and these samples were sent to the laboratory department at An Najah National University Hospital to test the patients’ HbA1c level.

Ethical approval

The Institutional Review Board (IRB) at An-Najah National University and Palestinian MOH approved our study protocol. We also obtained verbal consent from each patient before including him/her in our study. Approval for blood sample withdrawal was obtained from the MOH and from each patient.

Statistical analysis

We entered our data and analyzed it using SPSS (IBM SPSS Statistic, version 21: IBM, Armonk, NY, USA) program. Data were expressed as mean (standard deviation) or median (interquartile range) or frequency (percentage). HRQOL was the dependent variable. Socio-demographic and hemodialysis related clinical factors were the independent factors. We used the Kruskal-Wallis or Mann-Whitney U test for data that were not normally distributed. We also assessed the normality of distribution of data using the Kolmogorov-Smirnov test. Median (interquartile range) was used to describe non-normally distributed variables. Internal consistency was assessed using Cronbach's α. The significance level was set at P < 0.05. We entered the independent variables such as gender, marital status, education level, occupational status, and total chronic diseases as dummy coding of 0 and 1. We tested associations between clinical and socio-demographic factors and HRQOL score with multiple linear regression to control for potential confounding factors.

Results

Socio-demographic and clinical features

A total of 141 diabetic patients undergoing hemodialysis participated in this cross sectional study out of 150 recruited, giving a response rate of 94%. Overall, 52.5% of them (74 patients) were males while 47.5% (67 patients) were females. Studied patients had a mean age of 60.32 with 52.5% of them aged below 60.The majority of our patients (44%) were obese with BMI above 30. Most of the recruited sample (81 patients) were living in a village, and 95.7% of patients in our sample were living with their family. The sample had a poor educational level, as only 28 (19.9%) graduated from school. The vast majority of patients were unemployed (89.4%), and so 71 out of 141 patients reported having low household income monthly. Regarding dialysis sessions, 87 patients (61.7%) had been having regular hemodialysis for less than four years and 123 patients (87.2%) were having 3 or more dialysis sessions weekly. Only 3 patients reported having a history of kidney transplant. 22.7% of patients were smokers and only 40 (28.4%) had three or more chronic diseases. Ninety-two patients (65.2%) were taking fewer than eight chronic medications. Other clinical and socio-demographic features are shown in Table 1.

Table 1.

Socio-demographic and clinical features of the studied sample

Variable Number (%)
n = 141
Age category
 Age <60 74 (52.5)
 Age >60 67 (47.5)
Gender
 Male 74 (52.5)
 Female 67 (47.5 )
BMI
 Underweight 1 (0.7)
 Normal range 37 (26.2)
 Preobese (overweight) 41 (29.1)
 Obese 62 (44)
Residency
 Village 81 (57.4)
 City 47 (33.3)
 Palestinian refugee camp 13 (9.2)
Living status
 Live with family 135 (95.7)
 Live alone 6 (4.3)
Education level
 No formal education 17 (12.1)
 Primary 35 (24.8)
 Secondary 61 (43.3)
 Graduated 28 (19.9)
Marital status
 Single , Widow ,Divorced 28 (19.9)
 Married 113 (80.1)
Occupation
 Unemployed 126 (89.4)
 Employed 15 (10.6)
Household income (month)
 Low (less than 400 JD a) 71 (50.4)
 Moderate (400–1000 JD) 57 (40.4)
 High (more than 1000 JD) 13 (9.2)
Smoking
 Not smoker 109 (77.3)
 Smoker 32 (22.7)
Diabetes duration
 1-3 years 8 (5.7)
 4-5 years 3 (2.1)
 More than 5 years 130 (92.2)
Dialysis vintage (Years)
 Less than 4 years 87 (61.7)
 4 years or more 54 (38.3)
Dialysis frequency
 2 days or less 18 (12.8)
 3 days or more 123 (87.2)
Dialysis session duration (hours)
 Less than 4 hours 120 (85.1)
 4 hours or more 21 (14.9)
Kidney transplant
 Yes 3 (2.1)
 No 138 (97.9)
Total chronic diseases
 None 7 (5)
 One 48 (34)
 Two 46 (32.6)
 Three or more 40 (28.4)
Total chronic medications
 Less than 8 92 (65.2)
 8 or more 49 (34.8)
HbA1c
 Controlled(≤7) 92 (65.2)
 Uncontrolled(>7) 49 (34.8)

Abbreviations: BMI body mass index, JD Jordanian Dinar, HbA1c glycated haemoglobin

a1 Jordanian Dinar (JD) equals 1.41 US Dollar

Quality of life and health status

In Palestinian diabetic patients undergoing hemodialysis in the North West Bank, we found that the mean EQ-5D-5L index value was 0.314, with median of 0.31 ± 0.4. The mean (± standard deviation) EQ-VAS score was 50.85 (±22.43). The number (percentile) of patients who answered “severe problems” for the five items of QOL was as follows: mobility 25 (17), usual activities 56 (38.1), self-care 46 (31.3), pain/discomfort 9 (6.1) and anxiety/depression 29(19.7) Fig. 1.

Fig 1.

Fig 1

Distribution of HRQOL measures in different EQ-5D items among diabetic patients undergoing hemodialysis

EQ-5D-5L index values

The variables that displayed a statistically significant association with the EQ-5D were: patient’s gender, education level, marital status, occupational status, and total chronic diseases (all P values were less than 0.05). On the other side, patient’s age, BMI, residency, living status, household income, smoking, dialysis time, DM time, dialysis frequency, dialysis duration, kidney transplant, total chronic medications, and HbA1c level were not significantly associated with HRQOL (all P values were more than 0.05). For more details regarding the association between clinical and socio-demographic variables and EQ-5D total score, see Table 2.

Table 2.

The association between EQ-5D total score and socio-demographic and clinical variables among diabetic patients undergoing hemodialysis (n = 141)

Variable Number (%)
n = 141
Median [1st percentile-3rdpercentile] P value b
Age category
 Age <60 74 (52.5) 0.36 [0.13-0.71] 0.130
 Age >60 67 (47.5) 0.22 [-0.04-0.62]
Gender
 Male 74 (52.5) 0.47 [0.13-0.76] 0.001
 Female 67 (47.5 ) 0.22 [-0.04-0.41]
BMI
 Underweight 1 (0.7) 0.525
 Normal weight 37 (26.2) 0.32 [0.1-0.7]
 Preobese (overweight) 41 (29.1) 0.34 [0.04-0.66]
 Obese 62 (44) 0.23 [-0.08-0.63]
Residency
 Village 81 (57.4) 0.31 [-0.02-0.61] 0.645
 City 47 (33.3) 0.26 [-0.07-0.69]
 Palestinian refugee camp 13 (9.2) 0.43 [0.05-0.77]
Living status
 Live with family 135 (95.7) 0.32 [-0.02-0.67] 0.309
 Live alone 6 (4.3) 0.23 [0.06-0.27]
Education level
 No formal education 17 (12.1) -0.03 [-0.16-0.22] 0.026
 Primary 35(24.8) 0.41 [-0.04-0.72]
 Secondary 61 (43.3) 0.34 [ 0.07-0.62]
 Graduated 28(19.9) 0.42 [0.18-0.81]
Marital status
 Single, Widow, Divorced 28(19.9) 0.14 [-0.09-0.27] 0.001
 Married 113(80.1) 0.41 [0.04-0.71]
Occupation
 Unemployed 126(89.4) 0.29 [-0.04-0.59] 0.001
 Employed 15 (10.6) 0.68 [0.36-0.91]
Household income (month)
 Low (less than 400 JDa) 71 (50.4) 0.28 [-0.04-0.62] 0.432
 Moderate (400–1000 JD) 57 (40.4) 0.32 [0.06-0.71]
 High (more than 1000 JD) 13(9.2) 0.41 [0.18-0.87]
Smoking
 Not smoker 109(77.3) 0.31 [-0.02-0.65] 0.976
 Smoker 32 (22.7) 0.35 [-0.02-0.66]
Diabetes duration
 1-3 years 8(5.7) 0.28 [-0.13-0.7] 0.829
 4-5 years 3(2.1) 0.46 [0.04-]
 More than 5 years 130(92.2) 0.31 [-0.02-0.64]
Dialysis vintage (Years)
 Less than 4 years 87 (61.7) 0.32 [-0.02-0.69] 0.835
 4 years or more 54 (38.3) 0.31 [-0.03-0.62]
Dialysis frequency
 2 days or less 18 (12.8) 0.14 [-0.18-0.54] 0.117
 3 days or more 123 (87.2) 0.32 [0.02-0.66]
Dialysis session duration (hours)
 Less than 4 hours 120 (85.1) 0.31 [-0.02-0.64] 0.901
 4 hours or more 21 (14.9) 0.32 [-0.02-0.7]
Kidney transplant
 Yes 3 (2.1) 0.46 [0.178- 0.466
 No 138 (97.9) 0.31 [-0.02-0.64]
Total chronic diseases
 None 7 (5) 0.77 [0.61-0.88] 0.021
 One 48 (34) 0.31 [0.14-0.61]
 Two 46 (32.6) 0.36 [0.01-0.67]
 Three or more 40 (28.4) 0.11 [-0.09-0.51]
Total chronic medications
 Less than 8 92 (65.2) 0.31 [-0.07-0.59] 0.301
 8 or more 49 (34.8) 0.32 [0.07-0.70]
HbA1c
 Controlled(<7) 92 (65.2) 0.29 [0.01-0.66] 0.596
 Uncontrolled(>7) 49 (34.8) 0.41 [-0.05-0.65]

Abbreviations: BMI body mass index, JD Jordanian Dinar, HbA1c glycated haemoglobin

a1 Jordanian Dinar (JD) equals 1.41 US Dollar

bThe p-values are bold where they are less than the significance level cut-off of 0.05

Table 3 presents the multivariate associations between HRQOL scores and patients’ gender, education level, marital status, occupational status, and total chronic diseases. As shown in Table 3, marital status and occupational status were significantly (p < 0.05) associated with the QOL score. More specifically, married status and being employed were positively associated with QOL score (β = 0.22; p = 0.016 and β = 0.27; p = 0.013, respectively).

Table 3.

Multivariate associations between health-related quality of life scorea and four predictors among diabetic patients undergoing hemodialysis

Variablesb, c Unstandardized Coefficients Standardized Coefficients t P valued
B Std. Error Beta
Gender
 Male Ref. 0.207
 Female -0.09 0.07 -0.12 -1.27
Education level
 Under-university levels Ref. 0.380
 University level 0.07 0.08 0.07 0.88
Marital status
 Single, Widow, Divorced Ref. 0.016
 Married 0.22 0.09 0.21 2.45
Occupational status
 Unemployed Ref. 0.013
 Employed 0.27 0.11 0.21 2.51
Total chronic diseases
 Less than three Ref. 0.065
 Three or more -0.13 0.07 -0.15 -1.86

ahealth-related quality of life is a five-item scale assessing five separate dimensions of health (high score meaning better quality of life)

bUnivariate variables with p values < 0.05 were entered into the multiple linear regression

cNominal variables were entered into analyses using dummy coding

dThe p-values are bold where they are less than the significance level cut-off of 0.05

Discussion

In our study, we have evaluated the HRQOL among hemodialysis patients with DM at the North of West Bank, Palestine. Although HRQOL among patients undergoing hemodialysis in Palestine was studied previously [19], and also HRQOL among Palestinian diabetic patients [6], there are no data regarding HRQOL specifically between diabetic patients undergoing hemodialysis. We evaluated the HRQOL using the EQ-5D. On reviewing the literature, HRQOL was assessed in diabetic patients using the EQ-5D in various nations [2, 6, 2630]; also, this scale was used to measure HRQOL among patients undergoing hemodialysis [19, 3133], but our study is the first of its kind to use the EQ-5D to assess HRQOL among diabetic dialysis patients. Diabetic dialysis patients have significantly more complications and lower HRQOL compared to diabetic patients not undergoing hemodialysis [5, 34].

Our study showed that the mean EQ-5D score in hemodialysis patients with DM was 0.314 (SD 0.4) with mean EQ-VAS score for same patients of 50.85 (SD 22.43). Because no studies used these scores among diabetic dialysis patients, we were unable to compare EQ-5D score and EQ-VAS score means with any from past research. However, other studies using the same instrument among diabetic patients found the mean EQ-5D score as follows: Palestine 0.7 ± 0.20 [6], Norway 0.81 (SD 0.22) [2]. Moreover, the mean EQ-5D score among patients on hemodialysis was 0.37 ± 0.44 in Palestine [19]. The mean EQ-5D score among diabetic dialysis patients in our study was lower than that of diabetic patients or patients on hemodialysis, which was expected due to the combination of complications resulting from both DM and hemodialysis. However, it was obvious that HRQOL in patients on hemodialysis alone or diabetic dialysis patients is worse than that of patients with DM alone, showing the significance of dialysis and its complications on patients’ quality of life, which is consistent with conclusions from many previous studies [11, 35].

This study has shown that female patients had lower HRQOL than male patients. Other studies on diabetic patients found the same result. For example, Wexler et al.’s study [36] exploring correlates of HRQOL in type 2 DM using the Health Utilities Index-III found that female sex was one of the significant factors associated with decreased patient HRQOL. Another study [19] on Palestinian patients on hemodialysis using EQ-5D score found the same result. This result can be explained by the nature of females’ lifestyle in a developing country such as Palestine, which is mainly a sedentary lifestyle [37], and the low level of involvement of females in social activities. Passchier et al. emphasizes the major consequences of social activities for patients’ QOL [38]. Moreover, patients who were single, divorced or widowed were found to have significantly decreased HRQOL. That is consistent with a previous study that found marital status to be a significant predictor of HRQOL among diabetic patients in Gaza [39]. Additional international studies found the same result [40, 41]. A possible explanation for this might be that patients who aren’t married are more likely to have poor family support and to be isolated socially, so this can lead to decreased adherence to the prescribed hemodialysis and other treatment orders [42].

Our results demonstrated that increased educational level was associated with higher HRQOL. This may be because patients with a higher education level are likely to have a better understanding of their illness, its complications, and the importance of adherence to dialysis sessions and other treatment modalities [43]. Many studies found that education level is a significant determinant of HRQOL among both diabetic patients [6, 43] and patients on hemodialysis [19, 38, 44]. Furthermore, we found that unemployed patients had lower HRQOL than employed patients. Javanbakht et al. [43] found in a study on Iranian diabetic patients that most patients who answered having extreme problems in the items on the EQ-5D were unemployed. Unemployment was also found to be highly associated with poor HRQOL scores in other studies on hemodialysis patients [19, 4446]. This seems logical, as unemployed patients are more likely to be depressed [47], be socially inactive and have lower income, which can lead to impaired patients’ HRQOL [48].

As for clinical factors, we found that the more chronic diseases the patient had, the more likely he/she was to have poor HRQOL scores. A study on Iranian Muslim patients undergoing hemodialysis found that having DM or other comorbidity was related to patients’ QOL [49]. In addition, Yang et al. [50] studied HRQOL in Singapore and found that low Charlson comorbidity index was significantly associated with better HRQOL in Asian patients with renal failure. This finding can be explained as the more comorbidities the patient has, the lower physical activity and as a result QOL he will have [51].

Strengths and limitations

Notwithstanding the relatively limited sample, this work had many positive points. For example, it was the first study of our knowledge to use EQ-5D-5L among diabetic patients undergoing hemodialysis. Moreover, this was the first study in Palestine to assess HRQOL in diabetic dialysis patients. In addition, we included patients from both urban and rural areas because of the multi-center design of the study. On the other hand, there were some limitations we have to mention. First of all, we can’t identify a cause-effect relationship because of the cross-sectional nature of the study. Secondly, we didn’t include a generalized sample, as we included only six dialysis centers out of 11 dialysis centers in West Bank. Thirdly, the absence of control groups (i.e. diabetic patients not on maintenance dialysis and non-diabetic patients on maintenance dialysis) limits the interpretation of the disease burden on HRQOL. Lastly, there were some clinical and social factors that might affect patients’ QOL that we didn’t include in our study, such as diet, and some laboratory values.

Conclusions

Among diabetic patients undergoing hemodialysis, married status and being employed were associated with modestly higher QOL scores. In order to improve the QOL of diabetic patients undergoing hemodialysis, we recommend that healthcare providers give more attention to diabetic dialysis patients who are unemployed and unmarried, as they are at higher risk of having impaired HRQOL.

Additional file

Additional file 1: (107.3KB, docx)

Study questionnaires. This is the final version of the English and Arabic version that was used to obtain data which will help to address the factors associated with impaired health-related quality of life (HRQOL) in hemodialysis patients with diabetes in Palestine. (DOCX 107 kb)

Acknowledgments

The authors would like to thank An-Najah National University for giving the opportunities to conduct this study.

Funding

The study was partially funded by An-Najah National University to cover the costs of laboratory analysis.

Availability of data and materials

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

Abbreviations

BMI

Body mass index

DM

Diabetes mellitus

EQ-5D-5L

Five-level EuroQol five-dimensional instrument

EQ-VAS

Euroqol-visual analogue scale

ESRD

End-stage renal disease

HbA1c

Glycated haemoglobin

HRQOL

Health-related quality of life

IRB

INSTITUTIONAL Review Board

JD

Jordanian dinner

MOH

Ministry of Health

QOL

Quality of life

SD

Standard deviation

Authors’ contributions

SK collected data, performed the analyses, and literature search, and drafted the manuscript. MH, SH and EK participated in the collected data and literature search. SZ conceptualised and designed the study, coordinated, supervised and analysed the data, critically reviewed the manuscript and the interpretation of the results, and assisted in the final write-up of the manuscript. Then, all read and approved the final manuscript.

Ethics approval and consent to participate

The Institutional Review Board (IRB) at An-Najah National University and Palestinian MOH approved our study protocol. We also obtained verbal consent from each patient before including him/her in our study. Approval for blood sample withdrawal was obtained from the MOH and from each patient. This study protocol was approved (including the verbal consent process) by the IRB and did not require written consent according to IRB criteria.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Footnotes

Electronic supplementary material

The online version of this article (10.1186/s12882-018-0849-x) contains supplementary material, which is available to authorized users.

Contributor Information

Sohaib T. Khatib, Email: su1994haib@yahoo.com

Mohammad K. Hemadneh, Email: Dr.moh94@gmail.com

Samer A. Hasan, Email: Samer_abu_hashish@hotmail.com

Emad Khazneh, Email: Emad.khazneh@gmail.com.

Sa’ed H. Zyoud, Email: saedzyoud@yahoo.com, Email: saedzyoud@najah.edu

References

  • 1.Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2010;87(1):15–19. doi: 10.1016/j.diabres.2009.10.006. [DOI] [PubMed] [Google Scholar]
  • 2.Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes. 2010;8(1):18. doi: 10.1186/1477-7525-8-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Di Lullo L, Mangano M, Ronco C, Barbera V, De Pascalis A, Bellasi A, Russo D, Di Iorio B, Cozzolino M. The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents. Diabetes Metab Syndr. 2017;11(Suppl 1):S295–s305. doi: 10.1016/j.dsx.2017.03.005. [DOI] [PubMed] [Google Scholar]
  • 4.Caramori ML, Mauer M. Diabetes and nephropathy. Curr Opin Nephrol Hypertens. 2003;12(3):273–282. doi: 10.1097/00041552-200305000-00008. [DOI] [PubMed] [Google Scholar]
  • 5.Osthus TB, von der Lippe N, Ribu L, Rustoen T, Leivestad T, Dammen T, Os I. Health-related quality of life and all-cause mortality in patients with diabetes on dialysis. BMC Nephrol. 2012;13(1):78. doi: 10.1186/1471-2369-13-78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zyoud SH, Al-Jabi SW, Sweileh WM, Arandi DA, Dabeek SA, Esawi HH, Atyeh RH, Abu-Ali HA, Sleet YI, Abd-Alfatah BM, et al. Relationship of treatment satisfaction to health-related quality of life among Palestinian patients with type 2 diabetes mellitus: Findings from a cross-sectional study. J Clin Transl Endocrinol. 2015;2(2):66–71. doi: 10.1016/j.jcte.2015.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fukuhara S, Yamazaki S, Hayashino Y, Green J. Measuring health-related quality of life in patients with end-stage renal disease: why and how. Nat Clin Pract Nephrol. 2007;3(7):352–353. doi: 10.1038/ncpneph0510. [DOI] [PubMed] [Google Scholar]
  • 8.Dashti-Khavidaki S, Sharif Z, Khalili H, Badri S, Alimadadi A, Ahmadi F, Gatmiri M, Rahimzadeh S. The use of pharmaceutical care to improve health-related quality of life in hemodialysis patients in Iran. Int J Clin Pharm. 2013;35(2):260–267. doi: 10.1007/s11096-012-9748-6. [DOI] [PubMed] [Google Scholar]
  • 9.Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 1994;17(4):267–274. doi: 10.2337/diacare.17.4.267. [DOI] [PubMed] [Google Scholar]
  • 10.Sorensen VR, Mathiesen ER, Watt T, Bjorner JB, Andersen MV, Feldt-Rasmussen B. Diabetic patients treated with dialysis: complications and quality of life. Diabetologia. 2007;50(11):2254–2262. doi: 10.1007/s00125-007-0810-1. [DOI] [PubMed] [Google Scholar]
  • 11.Fukuhara S, Lopes AA, Bragg-Gresham JL, Kurokawa K, Mapes DL, Akizawa T, Bommer J, Canaud BJ, Port FK, Held PJ. Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2003;64(5):1903–1910. doi: 10.1046/j.1523-1755.2003.00289.x. [DOI] [PubMed] [Google Scholar]
  • 12.Landman GW, van Hateren KJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ. Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18) Diabetes Care. 2010;33(11):2378–2382. doi: 10.2337/dc10-0979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kleefstra N, Landman GW, Houweling ST, Ubink-Veltmaat LJ, Logtenberg SJ, Meyboom-de Jong B, Coyne JC, Groenier KH, Bilo HJ. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4) Diabetes Care. 2008;31(5):932–933. doi: 10.2337/dc07-2072. [DOI] [PubMed] [Google Scholar]
  • 14.Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol. 2001;12(12):2797–2806. doi: 10.1681/ASN.V12122797. [DOI] [PubMed] [Google Scholar]
  • 15.Martinez-Castelao A, Gorriz JL, Garcia-Lopez F, Lopez-Revuelta K, De Alvaro F, Cruzado JM. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study) J Nephrol. 2004;17(4):544–551. [PubMed] [Google Scholar]
  • 16.Ministry of Health, Palestinian Health Information Center. Health Annual Report Palestine 2015. 2016 [cited; Available from: http://www.moh.ps/Content/Books/NWNJXX7RJ92Bn4f5EGYiH43a2tjAAzKBnseGnEUCaqWqYZndsbCcPy_JQWguvkHTR4Xk4zUpdT45ooWxH11BhIbVAxwpGWy2wiwHdGcM5K7aZ.pdf.
  • 17.Al-Jabi SW, Zyoud SH, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R. Relationship of treatment satisfaction to health-related quality of life: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Expect. 2015;18(6):3336–3348. doi: 10.1111/hex.12324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Abu Farha NH, Khatib MT, Salameh H, Zyoud SH. Cancer-related post-treatment pain and its impact on health-related quality of life in breast cancer patients: a cross sectional study in Palestine. Asia Pac Fam Med. 2017;16(1):7. doi: 10.1186/s12930-017-0037-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zyoud SH, Daraghmeh DN, Mezyed DO, Khdeir RL, Sawafta MN, Ayaseh NA, Tabeeb GH, Sweileh WM, Awang R, Al-Jabi SW. Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine. BMC Nephrol. 2016;17(1):44. doi: 10.1186/s12882-016-0257-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Horowitz E, Abadi-Korek I, Shani M, Shemer J. EQ-5D as a generic measure of health-related quality of life in Israel: reliability, validity and responsiveness. Isr Med Assoc J. 2010;12(12):715–720. [PubMed] [Google Scholar]
  • 21.Garcia-Alcala H, Ruiz-Arguelles A, Cedillo-Carvallo B. Effect of the method to measure levels of glycated hemoglobin on individual clinical decisions: comparison of an immunoassay with high-performance liquid chromatography. Am J Clin Pathol. 2009;132(3):332–335. doi: 10.1309/AJCPIWRO1ST6HCIY. [DOI] [PubMed] [Google Scholar]
  • 22.Sonthon P, Promthet S, Changsirikulchai S, Rangsin R, Thinkhamrop B, Rattanamongkolgul S, Hurst CP. The impact of the quality of care and other factors on progression of chronic kidney disease in Thai patients with Type 2 Diabetes Mellitus: A nationwide cohort study. PLoS One. 2017;12(7):e0180977. doi: 10.1371/journal.pone.0180977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.EuroQOL Group. EQ-5D-5L User Guide: Basic information on how to use the EQ-5D-5L instrument. 2011 [cited 2013 January 7]; Available from: http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/UserGuide_EQ-5D-5L.pdf.
  • 24.Zyoud SH, Al-Jabi SW, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R, Morisky DE. Health-related quality of life associated with treatment adherence in patients with hypertension: a cross-sectional study. Int J Cardiol. 2013;168(3):2981–2983. doi: 10.1016/j.ijcard.2013.04.105. [DOI] [PubMed] [Google Scholar]
  • 25.EuroQol Group. EQ-5D-5L Crosswalk Index Value Calculator. 2016 [cited 2016 November 30]; Available from: http://www.euroqol.org/fileadmin/user_upload/Documenten/Excel/Crosswalk_5L/EQ-5D-5L_Crosswalk_Index_Value_Calculator.v2.xls.
  • 26.Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62) Med Decis Making. 2002;22(4):340–349. doi: 10.1177/027298902400448902. [DOI] [PubMed] [Google Scholar]
  • 27.Lee WJ, Song KH, Noh JH, Choi YJ, Jo MW. Health-related quality of life using the EuroQol 5D questionnaire in Korean patients with type 2 diabetes. J Korean Med Sci. 2012;27(3):255–260. doi: 10.3346/jkms.2012.27.3.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25(3):458–463. doi: 10.2337/diacare.25.3.458. [DOI] [PubMed] [Google Scholar]
  • 29.Sakamaki H, Ikeda S, Ikegami N, Uchigata Y, Iwamoto Y, Origasa H, Otani T, Otani Y. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health. 2006;9(1):47–53. doi: 10.1111/j.1524-4733.2006.00080.x. [DOI] [PubMed] [Google Scholar]
  • 30.Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000;14(5):235–241. doi: 10.1016/S1056-8727(00)00133-1. [DOI] [PubMed] [Google Scholar]
  • 31.Manns B, Johnson J, Taub K, Mortis G, Ghali W, Donaldson C. Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol. 2003;60(5):341–351. doi: 10.5414/CNP60341. [DOI] [PubMed] [Google Scholar]
  • 32.Manns BJ, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C. Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J. 2002;48(5):565–569. doi: 10.1097/00002480-200209000-00021. [DOI] [PubMed] [Google Scholar]
  • 33.Tajima R, Kondo M, Kai H, Saito C, Okada M, Takahashi H, Doi M, Tsuruoka S, Yamagata K. Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D) Clin Exp Nephrol. 2010;14(4):340–348. doi: 10.1007/s10157-010-0304-1. [DOI] [PubMed] [Google Scholar]
  • 34.Ahola AJ, Saraheimo M, Forsblom C, Hietala K, Sintonen H, Groop PH. Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study) Nephrol Dial Transplant. 2010;25(6):1903–1908. doi: 10.1093/ndt/gfp709. [DOI] [PubMed] [Google Scholar]
  • 35.Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis. 2000;35(1):69–79. doi: 10.1016/S0272-6386(00)70304-0. [DOI] [PubMed] [Google Scholar]
  • 36.Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, Blais MA, Meigs JB. Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006;49(7):1489–1497. doi: 10.1007/s00125-006-0249-9. [DOI] [PubMed] [Google Scholar]
  • 37.Merom D, Sinnreich R, Aboudi V, Kark JD, Nassar H. Lifestyle physical activity among urban Palestinians and Israelis: a cross-sectional comparison in the Palestinian-Israeli Jerusalem risk factor study. BMC Public Health. 2012;12(1):90. doi: 10.1186/1471-2458-12-90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kao TW, Lai MS, Tsai TJ, Jan CF, Chie WC, Chen WY. Economic, social, and psychological factors associated with health-related quality of life of chronic hemodialysis patients in northern Taiwan: a multicenter study. Artif Organs. 2009;33(1):61–68. doi: 10.1111/j.1525-1594.2008.00675.x. [DOI] [PubMed] [Google Scholar]
  • 39.Eljedi A, Mikolajczyk RT, Kraemer A, Laaser U. Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in the Gaza strip: a cross-sectional study. BMC Public Health. 2006;6(1):268. doi: 10.1186/1471-2458-6-268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health. 2007;7(1):186. doi: 10.1186/1471-2458-7-186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Trief PM, Wade MJ, Britton KD, Weinstock RS. A prospective analysis of marital relationship factors and quality of life in diabetes. Diabetes Care. 2002;25(7):1154–1158. doi: 10.2337/diacare.25.7.1154. [DOI] [PubMed] [Google Scholar]
  • 42.Untas A, Thumma J, Rascle N, Rayner H, Mapes D, Lopes AA, Fukuhara S, Akizawa T, Morgenstern H, Robinson BM, et al. The associations of social support and other psychosocial factors with mortality and quality of life in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol. 2011;6(1):142–152. doi: 10.2215/CJN.02340310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Javanbakht M, Abolhasani F, Mashayekhi A, Baradaran HR, Jahangiri noudeh Y. Health related quality of life in patients with type 2 diabetes mellitus in Iran: a national survey. PLoS One. 2012;7(8):e44526. doi: 10.1371/journal.pone.0044526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Lopes AA, Bragg-Gresham JL, Goodkin DA, Fukuhara S, Mapes DL, Young EW, Gillespie BW, Akizawa T, Greenwood RN, Andreucci VE, et al. Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Quality of Life Research. 2007;16(6):1095. doi: 10.1007/s11136-007-9213-5. [DOI] [PubMed] [Google Scholar]
  • 45.Al Wakeel J, Al Harbi A, Bayoumi M, Al-Suwaida K, Al Ghonaim M, Mishkiry A. Quality of life in hemodialysis and peritoneal dialysis patients in Saudi Arabia. Ann Saudi Med. 2012;32(6):570–574. doi: 10.5144/0256-4947.2012.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Garcia-Llana H, Remor E, Selgas R. Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis. Psicothema. 2013;25(1):79–86. doi: 10.7334/psicothema2012.96. [DOI] [PubMed] [Google Scholar]
  • 47.Stankunas M, Kalediene R, Starkuviene S, Kapustinskiene V. Duration of unemployment and depression: a cross-sectional survey in Lithuania. BMC Public Health. 2006;6(1):174. doi: 10.1186/1471-2458-6-174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Park HC, Yoon HB, Son MJ, Jung ES, Joo KW, Chin HJ, Oh KH, Lim CS, Kim YS, Ahn C, et al. Depression and health-related quality of life in maintenance hemodialysis patients. Clin Nephrol. 2010;73(5):374–380. doi: 10.5414/CNP73374. [DOI] [PubMed] [Google Scholar]
  • 49.Saffari M, Pakpour AH, Naderi MK, Koenig HG, Baldacchino DR, Piper CN. Spiritual coping, religiosity and quality of life: a study on Muslim patients undergoing haemodialysis. Nephrology (Carlton) 2013;18(4):269–275. doi: 10.1111/nep.12041. [DOI] [PubMed] [Google Scholar]
  • 50.Yang F, Griva K, Lau T, Vathsala A, Lee E, Ng HJ, Mooppil N, Foo M, Newman SP, Chia KS, et al. Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in Singapore. Qual Life Res. 2015;24(9):2163–2171. doi: 10.1007/s11136-015-0964-0. [DOI] [PubMed] [Google Scholar]
  • 51.O'Shea MP, Teeling M, Bennett K. Comorbidity, health-related quality of life and self-care in type 2 diabetes: a cross-sectional study in an outpatient population. Ir J Med Sci. 2015;184(3):623–630. doi: 10.1007/s11845-014-1190-4. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional file 1: (107.3KB, docx)

Study questionnaires. This is the final version of the English and Arabic version that was used to obtain data which will help to address the factors associated with impaired health-related quality of life (HRQOL) in hemodialysis patients with diabetes in Palestine. (DOCX 107 kb)

Data Availability Statement

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.


Articles from BMC Nephrology are provided here courtesy of BMC

RESOURCES